In this episode, Paul Holmes talks to Silvia Taylor, SVP of corporate affairs at Novavax, and Adam Hildreth, founder/CEO of Crisp, about the reputation issues facing the pharmaceutical industry as the largest vaccine effort in the world rolls out to combat Covid-19. The group also addresses the disinformation Novavax had to deal with as part of their clinical trials and how the global pandemic has accelerated the urgency for transparency and humanity in healthcare communications.
Gail Heimann's PR industry lessons from Cannes (Ep. 88)
Cannes: Ruth Yearley and Tera Miller on being creative at work (Ep. 87)
H+K Strategies CEO Jack Martin (Ep. 86)
Partner Content: Hacks & Flacks - There’s No Bad Time for Pop Tarts
Cannes preview & UK General Election lessons with Quartz's Jason Karaian and Tory candidate Dean Russell (Ep. 85)
Creativity Series: Why Diversity Matters for Creativity (Ep. 84)
Jo-Ann Robertson on the UK General Election (Ep. 83)
In2Summit EMEA 2017: Purpose, fake news & behavioural insights (Ep.82)
Subtle Ways Workplace Inequalities Happen (Ep. 81)
Holding groups vs independents; World's best marketing campaigns (Ep. 80)
Chris Owen on mental health & addiction in the PR industry (Ep. 79)
North American Agencies of the Year 2017 (Ep. 78)
Partner Content: Hacks & Flacks' Let Your Freak Flag Fly
Sechaba Motsieloa on bridging the in-house/agency divide (Ep. 77)
The fake news phenomenon
SXSWi 2017 Trends with Chad Latz
RFP Matchmaking at Globality; Rethinking Thought-Leadership
David Singleton; Maxim Behar
What is your corporate Trump strategy?
Alternative facts & Trump tweets with Sally Costerton
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money